Ship Healthcare Holdings, Inc. (FRA:5EZ)
Germany · Delayed Price · Currency is EUR 13.50
-0.20 (-1.46%)
At close: Jan 30, 2026
Ship Healthcare Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 701,582 | 678,229 | 630,988 | 572,285 | 514,353 | 497,156 | |
Revenue Growth (YoY) | 8.90% | 7.49% | 10.26% | 11.26% | 3.46% | 2.63% |
Cost of Revenue | 633,527 | 611,486 | 565,380 | 511,667 | 460,709 | 442,670 |
Gross Profit | 68,055 | 66,743 | 65,608 | 60,618 | 53,644 | 54,486 |
Selling, General & Admin | 42,840 | 41,964 | 41,071 | 39,473 | 33,138 | 32,685 |
Operating Expenses | 41,228 | 40,352 | 41,165 | 39,461 | 32,900 | 33,316 |
Operating Income | 26,827 | 26,391 | 24,443 | 21,157 | 20,744 | 21,170 |
Interest Expense | -478 | -499 | -449 | -424 | -283 | -325 |
Interest & Investment Income | 597 | 590 | 604 | 537 | 500 | 594 |
Earnings From Equity Investments | 493 | 1,091 | 725 | -5 | 357 | -40 |
Currency Exchange Gain (Loss) | 196 | -244 | -452 | -1,094 | -284 | 119 |
Other Non Operating Income (Expenses) | 298 | 295 | 345 | 436 | 252 | 243 |
EBT Excluding Unusual Items | 27,933 | 27,624 | 25,216 | 20,607 | 21,286 | 21,761 |
Gain (Loss) on Sale of Investments | 82 | 79 | -475 | 2 | 1 | -65 |
Gain (Loss) on Sale of Assets | 11 | 1 | 45 | 39 | - | -1 |
Asset Writedown | -587 | -472 | -2,720 | -27 | -484 | -419 |
Other Unusual Items | -2,878 | -2,904 | -206 | 45 | - | -41 |
Pretax Income | 24,561 | 24,328 | 21,860 | 20,666 | 20,803 | 21,235 |
Income Tax Expense | 9,512 | 9,353 | 8,123 | 9,061 | 8,418 | 8,873 |
Earnings From Continuing Operations | 15,049 | 14,975 | 13,737 | 11,605 | 12,385 | 12,362 |
Minority Interest in Earnings | -28 | 153 | 52 | 458 | -213 | -82 |
Net Income | 15,021 | 15,128 | 13,789 | 12,063 | 12,172 | 12,280 |
Net Income to Common | 15,021 | 15,128 | 13,789 | 12,063 | 12,172 | 12,280 |
Net Income Growth | -3.97% | 9.71% | 14.31% | -0.90% | -0.88% | 4.04% |
Shares Outstanding (Basic) | 94 | 94 | 94 | 94 | 94 | 94 |
Shares Outstanding (Diluted) | 94 | 94 | 94 | 104 | 104 | 104 |
Shares Change (YoY) | -0.37% | - | -9.21% | 0.03% | -0.09% | -0.65% |
EPS (Basic) | 159.80 | 160.34 | 146.15 | 127.85 | 129.01 | 129.99 |
EPS (Diluted) | 159.80 | 160.34 | 146.15 | 115.93 | 117.02 | 117.95 |
EPS Growth | -3.61% | 9.71% | 26.06% | -0.93% | -0.79% | 4.73% |
Free Cash Flow | 21,584 | 16,563 | 28,416 | 10,636 | 9,304 | 15,140 |
Free Cash Flow Per Share | 229.62 | 175.55 | 301.18 | 102.35 | 89.56 | 145.61 |
Dividend Per Share | 58.000 | 58.000 | 45.000 | 42.000 | 41.000 | 40.000 |
Dividend Growth | 28.89% | 28.89% | 7.14% | 2.44% | 2.50% | 6.67% |
Gross Margin | 9.70% | 9.84% | 10.40% | 10.59% | 10.43% | 10.96% |
Operating Margin | 3.82% | 3.89% | 3.87% | 3.70% | 4.03% | 4.26% |
Profit Margin | 2.14% | 2.23% | 2.19% | 2.11% | 2.37% | 2.47% |
Free Cash Flow Margin | 3.08% | 2.44% | 4.50% | 1.86% | 1.81% | 3.04% |
EBITDA | 34,170 | 33,760 | 31,882 | 28,607 | 26,232 | 26,297 |
EBITDA Margin | 4.87% | 4.98% | 5.05% | 5.00% | 5.10% | 5.29% |
D&A For EBITDA | 7,343 | 7,369 | 7,439 | 7,450 | 5,488 | 5,127 |
EBIT | 26,827 | 26,391 | 24,443 | 21,157 | 20,744 | 21,170 |
EBIT Margin | 3.82% | 3.89% | 3.87% | 3.70% | 4.03% | 4.26% |
Effective Tax Rate | 38.73% | 38.45% | 37.16% | 43.84% | 40.47% | 41.78% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.